找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer; Chad A. Mirkin,Thomas J. Meade,Alexander H. Stegh Book 201

[復制鏈接]
樓主: Hermit
21#
發(fā)表于 2025-3-25 07:18:22 | 只看該作者
Radiosensitization and Nanoparticles,hat enhance existing treatments for cancer, such as radiation therapy, are being explored in several different ways. Two general paths toward nanomaterial-enabled radiosensitization have been explored: (1) improving the effectiveness of ionizing radiation and (2) modulating cellular pathways leading
22#
發(fā)表于 2025-3-25 10:10:53 | 只看該作者
Hybrid Nanoparticles for Cancer Imaging and Therapy,is class of nanoparticles can not only retain the beneficial features of both inorganic and organic materials, but also allow systematic fine-tuning of their properties through the judicious combination of functional components. This chapter summarizes recent advances in the design and synthesis of
23#
發(fā)表于 2025-3-25 15:06:00 | 只看該作者
24#
發(fā)表于 2025-3-25 17:45:44 | 只看該作者
25#
發(fā)表于 2025-3-25 23:00:12 | 只看該作者
Engineering the Nanoparticle-Protein Interface for Cancer Therapeutics,nctional protein is still a major challenge. In addition, formation of protein corona on the surface of the nanoparticles can also alter the behavior of the nanoparticles. Here, we will review recent strategies for protein delivery into the cell. Finally we will discuss the issue of protein corona f
26#
發(fā)表于 2025-3-26 03:37:55 | 只看該作者
27#
發(fā)表于 2025-3-26 05:25:32 | 只看該作者
Cancer Nanotherapeutics in Clinical Trials,ribes the clinical trials required for a drug to gain approval. We then look at the different cancer nanotherapeutics and in vivo diagnostics that are currently in clinical trials or have already received approval. These nanotechnologies are catagorized and described based on the delivery vehicle: l
28#
發(fā)表于 2025-3-26 09:44:21 | 只看該作者
29#
發(fā)表于 2025-3-26 14:34:36 | 只看該作者
30#
發(fā)表于 2025-3-26 17:38:36 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 15:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
达拉特旗| 九龙城区| 桐城市| 沾益县| 潍坊市| 进贤县| 浑源县| 上林县| 桐乡市| 天门市| 石首市| 孟州市| 祁阳县| 赤峰市| 和静县| 长泰县| 根河市| 措美县| 平潭县| 特克斯县| 名山县| 襄城县| 阜康市| 平定县| 都江堰市| 万安县| 安仁县| 循化| 股票| 惠安县| 双峰县| 玉溪市| 元江| 林口县| 民县| 沅陵县| 龙门县| 大竹县| 南丹县| 甘泉县| 鄯善县|